KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Change in Acquisitions & Divestments (2023 - 2025)

Historic Change in Acquisitions & Divestments for Castle Biosciences (CSTL) over the last 3 years, with Q3 2025 value amounting to $54.9 million.

  • Castle Biosciences' Change in Acquisitions & Divestments rose 4918.48% to $54.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.8 million, marking a year-over-year increase of 1403.2%. This contributed to the annual value of $183.9 million for FY2024, which is 139.41% down from last year.
  • Per Castle Biosciences' latest filing, its Change in Acquisitions & Divestments stood at $54.9 million for Q3 2025, which was up 4918.48% from $44.0 million recorded in Q2 2025.
  • Castle Biosciences' 5-year Change in Acquisitions & Divestments high stood at $60.6 million for Q4 2024, and its period low was $36.2 million during Q2 2024.
  • For the 3-year period, Castle Biosciences' Change in Acquisitions & Divestments averaged around $46.0 million, with its median value being $45.0 million (2023).
  • The largest annual percentage gain for Castle Biosciences' Change in Acquisitions & Divestments in the last 5 years was 4918.48% (2025), contrasted with its biggest fall of 2768.92% (2025).
  • Quarter analysis of 3 years shows Castle Biosciences' Change in Acquisitions & Divestments stood at $48.5 million in 2023, then rose by 25.05% to $60.6 million in 2024, then dropped by 9.48% to $54.9 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $54.9 million for Q3 2025, versus $44.0 million for Q2 2025 and $36.3 million for Q1 2025.